<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin YC</submitter><funding>National Science and Technology Council, Taiwan</funding><funding>National Science and Technology Council (NSTC), Taiwan</funding><funding>National Health Research Institute (NHRI), Taiwan</funding><pagination>826</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11273629</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(7)</volume><pubmed_abstract>Oxidative stress resulting from reactive oxygen species (ROS) is often considered to be the leading cause of interstitial cystitis (IC), which is a chronic inflammatory disease. Antioxidants have been proven to have promising therapeutic effects on IC. In this study, we present an antioxidant intervention for IC by introducing curcumin-loaded cerium oxide nanoparticles (Cur-CONPs). Recognizing oxidative stress as the primary contributor to IC, our research builds on previous work utilizing cerium oxide nanoparticles (CONPs) for their outstanding antioxidant and anti-inflammatory properties. However, given the need to effectively relieve acute inflammation, we engineered Cur-CONPs to harness the short-term radical-scavenging antioxidant prowess of curcumin. Through in vitro studies, we demo</pubmed_abstract><journal>Antioxidants (Basel, Switzerland)</journal><pubmed_title>Characterization and Therapeutic Potential of Curcumin-Loaded Cerium Oxide Nanoparticles for Interstitial Cystitis Management.</pubmed_title><pmcid>PMC11273629</pmcid><funding_grant_id>BN-112-PP-01</funding_grant_id><funding_grant_id>111-2221-E-002-037-MY3</funding_grant_id><pubmed_authors>Lin YC</pubmed_authors><pubmed_authors>Liu LJ</pubmed_authors><pubmed_authors>Lin FH</pubmed_authors><pubmed_authors>Zhang CH</pubmed_authors><pubmed_authors>Liang YJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterization and Therapeutic Potential of Curcumin-Loaded Cerium Oxide Nanoparticles for Interstitial Cystitis Management.</name><description>Oxidative stress resulting from reactive oxygen species (ROS) is often considered to be the leading cause of interstitial cystitis (IC), which is a chronic inflammatory disease. Antioxidants have been proven to have promising therapeutic effects on IC. In this study, we present an antioxidant intervention for IC by introducing curcumin-loaded cerium oxide nanoparticles (Cur-CONPs). Recognizing oxidative stress as the primary contributor to IC, our research builds on previous work utilizing cerium oxide nanoparticles (CONPs) for their outstanding antioxidant and anti-inflammatory properties. However, given the need to effectively relieve acute inflammation, we engineered Cur-CONPs to harness the short-term radical-scavenging antioxidant prowess of curcumin. Through in vitro studies, we demo</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-30T03:11:07.647Z</modification><creation>2025-04-19T13:12:03.168Z</creation></dates><accession>S-EPMC11273629</accession><cross_references><pubmed>39061895</pubmed><doi>10.3390/antiox13070826</doi></cross_references></HashMap>